XML 15 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Cumulative Effect Period of Adoption Adjustment
Retained Earnings
Cumulative Effect Period of Adoption Adjustment Retained Earnings
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Total
Beginning balance (in shares) at Dec. 31, 2016     11,093,489        
Beginning balance at Dec. 31, 2016     $ 111 $ 35,453 $ 152,810   $ 188,374
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]              
Stock-based compensation       11,627     11,627
Issuance of restricted stock, net (in shares)     73,936        
Issuance of restricted stock, net     $ 1 (1)     0
Common stock dividends         (11,416)   (11,416)
Net income (loss)         20,612   20,612
Unrealized gains on marketable securities, net of tax             0
Ending balance (in shares) at Dec. 31, 2017     11,167,425        
Ending balance at Dec. 31, 2017     $ 112 47,079 162,006   209,197
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]              
Stock-based compensation       14,994     14,994
Issuance of restricted stock, net (in shares)     155,874        
Issuance of restricted stock, net     $ 1 (777)     (776)
Common stock dividends         (27,842)   (27,842)
Net income (loss)         (15,671)   (15,671)
Issuance of stock in connection with the acquisition of Capella Education Company (in shares)     10,263,775        
Issuance of stock in connection with the acquisition of Capella Education Company     $ 103 1,236,858     1,236,961
Filing fee related to new stock issuance       (148)     (148)
Exercise of stock options, net (in shares)     156,424        
Exercise of stock options, net     $ 1 8,647     8,648
Unrealized gains on marketable securities, net of tax           $ 32 32
Ending balance (in shares) at Dec. 31, 2018     21,743,498        
Ending balance at Dec. 31, 2018 $ (171) $ (171) $ 217 1,306,653 118,322 32 1,425,224
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]              
Stock-based compensation       12,033 83   12,116
Issuance of restricted stock, net (in shares)     117,947        
Issuance of restricted stock, net     $ 1 (7,473)     (7,472)
Common stock dividends         (46,724)   (46,724)
Net income (loss)         81,138   81,138
Exercise of stock options, net (in shares)     103,364        
Exercise of stock options, net     $ 2 (1,775)     (1,773)
Unrealized gains on marketable securities, net of tax           201 201
Ending balance (in shares) at Dec. 31, 2019     21,964,809        
Ending balance at Dec. 31, 2019     $ 220 $ 1,309,438 $ 152,819 $ 233 $ 1,462,710